Kemantane in recurrent aphthous stomatitis
Study involving people · 1990
- What was studied
- 30 Kemantane-treated patients with severe recurrent aphthous stomatitis.
- Main finding
- The authors reported faster lesion healing and longer remission in fibrous or scarring recurrent aphthous stomatitis. No effect size or time-to-healing figures appear in the abstract.
Reported findings and study design
Findings described in words
Clinical and blood-marker assessments in 30 treated patients with severe recurrent aphthous stomatitis.
Population or model 30 Kemantane-treated patients with severe recurrent aphthous stomatitis.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Lesion healing and remission | Earlier epithelialization and longer remissions reported in fibrous and scarring forms. | No numerical differences or comparator denominators available. |
Dose, course length, relapse duration and harms require the full article.
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- The abstract does not give the dose, schedule, comparator size, allocation methods or adverse-event counts.
Source details
Indexed English abstract of the original Russian journal report.
Sources checked
Citation
N. V. Terekhova, V. V. Khazanova, E. A. Zemskaia, et al.. Kemantane in recurrent aphthous stomatitis Stomatologiia (Mosk). 1990;69(1):31–33.